Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centers.
J Virus Erad. 2023 Jul 27;9(3):100338. doi: 10.1016/j.jve.2023.100338. eCollection 2023 Sep.
J Virus Erad. 2023.
PMID: 37663576
Free PMC article.
Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy.
Schwarz M, Schwarz C, Schütz A, Schwanke C, Krabb E, Schubert R, Liebich ST, Bauer D, Burghart L, Brinkmann L, Gutic E, Reiberger T, Haltmayer H, Gschwantler M.
Schwarz M, et al. Among authors: gutic e.
J Virus Erad. 2023 Mar 2;9(1):100319. doi: 10.1016/j.jve.2023.100319. eCollection 2023 Mar.
J Virus Erad. 2023.
PMID: 36970063
Free PMC article.
Item in Clipboard
Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease.
Moser S, Kozbial K, Laferl H, Schütz A, Reiberger T, Schwabl P, Gutic E, Schwanke C, Schubert R, Luhn J, Lang T, Schleicher M, Steindl-Munda P, Haltmayer H, Ferenci P, Gschwantler M.
Moser S, et al. Among authors: gutic e.
Eur J Gastroenterol Hepatol. 2018 Mar;30(3):291-295. doi: 10.1097/MEG.0000000000001027.
Eur J Gastroenterol Hepatol. 2018.
PMID: 29120906
Item in Clipboard
Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct-acting antivirals.
Schütz A, Moser S, Schwanke C, Schubert R, Luhn J, Gutic E, Lang T, Schleicher M, Haltmayer H, Gschwantler M.
Schütz A, et al. Among authors: gutic e.
J Viral Hepat. 2018 Jul;25(7):870-873. doi: 10.1111/jvh.12857. Epub 2018 Feb 6.
J Viral Hepat. 2018.
PMID: 29316001
Item in Clipboard
Directly observed therapy for HCV with glecaprevir/pibrentasvir alongside opioid substitution in people who inject drugs-First real world data from Austria.
Schmidbauer C, Schubert R, Schütz A, Schwanke C, Luhn J, Gutic E, Pirker R, Lang T, Reiberger T, Haltmayer H, Gschwantler M.
Schmidbauer C, et al. Among authors: gutic e.
PLoS One. 2020 Mar 10;15(3):e0229239. doi: 10.1371/journal.pone.0229239. eCollection 2020.
PLoS One. 2020.
PMID: 32155165
Free PMC article.
Item in Clipboard
Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapy.
Schmidbauer C, Schwarz M, Schütz A, Schubert R, Schwanke C, Gutic E, Pirker R, Lang T, Reiberger T, Haltmayer H, Gschwantler M.
Schmidbauer C, et al. Among authors: gutic e.
PLoS One. 2021 Jun 4;16(6):e0252274. doi: 10.1371/journal.pone.0252274. eCollection 2021.
PLoS One. 2021.
PMID: 34086708
Free PMC article.
Item in Clipboard
Early decrease of liver stiffness after initiation of antiviral therapy in patients with chronic hepatitis C.
Moser S, Gutic E, Schleicher M, Gschwantler M.
Moser S, et al. Among authors: gutic e.
Dig Liver Dis. 2016 Aug;48(8):970-1. doi: 10.1016/j.dld.2016.05.004. Epub 2016 May 17.
Dig Liver Dis. 2016.
PMID: 27260330
No abstract available.
Item in Clipboard
Cite
Cite